PHARMARESEARCH BIO Co., Ltd. (XKON: 217950)

Market Cap	130.31B
Revenue	n/a
Net Income	n/a
Shares Out	4.05M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	235
Open	32,600
Previous Close	32,650
Day's Range	31,950 - 33,000
52-Week Range	19,090 - 39,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PHARMARESEARCH BIO

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The co...

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 217950